The low molecular weight protein tyrosine phosphatase promotes adipogenesis and subcutaneous adipocyte hypertrophy
- 21 February 2021
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 236 (9), 6630-6642
- https://doi.org/10.1002/jcp.30307
Abstract
Obesity is a major contributing factor to the pathogenesis of Type 2 diabetes. Multiple human genetics studies suggest that high activity of the low molecular weight protein tyrosine phosphatase (LMPTP) promotes metabolic syndrome in obesity. We reported that LMPTP is a critical promoter of insulin resistance in obesity by regulating liver insulin receptor signaling and that inhibition of LMPTP reverses obesity‐associated diabetes in mice. Since LMPTP is expressed in adipose tissue but little is known about its function, here we examined the role of LMPTP in adipocyte biology. Using conditional knockout mice, we found that selective deletion of LMPTP in adipocytes impaired obesity‐induced subcutaneous adipocyte hypertrophy. We assessed the role of LMPTP in adipogenesis in vitro, and found that LMPTP deletion or knockdown substantially impaired differentiation of primary preadipocytes and 3T3‐L1 cells into adipocytes, respectively. Inhibition of LMPTP in 3T3‐L1 preadipocytes also reduced adipogenesis and expression of proadipogenic transcription factors peroxisome proliferator activated receptor gamma (PPARγ) and CCAAT/enhancer‐binding protein alpha. Inhibition of LMPTP increased basal phosphorylation of platelet‐derived growth factor receptor alpha (PDGFRα) on activation motif residue Y849 in 3T3‐L1, resulting in increased activation of the mitogen‐associated protein kinases p38 and c‐Jun N‐terminal kinase and increased PPARγ phosphorylation on inhibitory residue S82. Analysis of the metabolome of differentiating 3T3‐L1 cells suggested that LMPTP inhibition decreased cell glucose utilization while enhancing mitochondrial respiration and nucleotide synthesis. In summary, we report a novel role for LMPTP as a key driver of adipocyte differentiation via control of PDGFRα signaling.Funding Information
- University of Texas System (STAR Award)
- National Heart, Lung, and Blood Institute (R01 HL152717)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK063491, R01 DK106233)
- American Diabetes Association (1‐15‐INI‐13)
This publication has 47 references indexed in Scilit:
- Adipocyte-Specific Protein Tyrosine Phosphatase 1B Deletion Increases Lipogenesis, Adipocyte Cell Size and Is a Minor Regulator of Glucose HomeostasisPLOS ONE, 2012
- PPARγ contributes to PKM2 and HK2 expression in fatty liverNature Communications, 2012
- Regulation of adipogenic differentiation by LAR tyrosine phosphatase in human mesenchymal stem cells and 3T3-L1 preadipocytesJournal of Cell Science, 2009
- Metabolic phenotyping of a model of adipocyte differentiationPhysiological Genomics, 2009
- Down-regulation of Platelet-derived Growth Factor Receptor Expression during Terminal Differentiation of 3T3-L1 Pre-adipocyte FibroblastsOnline Journal of Public Health Informatics, 1996
- LowMrPhosphotyrosine Protein Phosphatase Interacts with the PDGF Receptor Directly via Its Catalytic SiteBiochemical and Biophysical Research Communications, 1996
- Inhibition of cellular response to platelet-derived growth factor by lowMrphosphotyrosine protein phosphatase overexpressionFEBS Letters, 1994
- Negative growth control by a novel lowMrphosphotyrosine protein phosphatase in normal and transformed cellsFEBS Letters, 1993
- Cloning, expression, and catalytic mechanism of the low molecular weight phosphotyrosyl protein phosphatase from bovine heartBiochemistry, 1992
- A possible genetic component of obesity in childhood. Observations on acid phosphatase polymorphismCellular and Molecular Life Sciences, 1990